biotech entrepreneur, and millionaire, Lindsay
Rosenwald, is reportedly selling his New York City penthouse apartment
for $65 million dollars. Located at the iconic luxury building, 15 Central Park
West, the nearly 6,000 square foot space features stunning views of Central
Park and an entire floor for entertaining guests.
has become very successful in recent years since becoming the Chief Executive
Officer (CEO) of biopharmaceutical company, Fortress Biotech. Recently, at
Rosenwald’s leadership, the company has forged two lucrative partnerships. One
partnership is with AstraZeneca and the other is with the Cincinnati
Children’s Hospital Medical Center.
The sale of Rosenwald’s 15 Central Park West
apartment also has the potential to be very lucrative as well. If able to find
a buyer, Lindsay
Rosenwald will more than double his investment in the property.
Dr. Lindsay Rosenwald is a medical doctor,
biotechnology entrepreneur, and financial expert. He has a B.S. in Finance and
Economy from Pennsylvania State University. Additionally, in 1983, he successfully
graduated with his M.D. from Temple University School of Medicine.
His unique expertise in both financial markets
and the medical field has certainly served him well throughout his life.
Over the course of his career, he has been a
part of a number of projects in the pharmaceuticals and investment industries.
Most recently since December of 2013, he has been President and Chief Executive
Officer of Fortress Biotech. His role as a leader has been to help the company
achieve financial success, exceed shareholder expectations, and build lucrative
partnerships within the industry.
In addition to his role with Fortress Biotech,
hs also serves as a director of Mustang Bio, Inc. and Checkpoint Therapeutics.
He is also on the Board of Directors of Avenue Therapeutics, Inc.
About Fortress Biotech
According to the company website, Fortress
Biotech’s purpose is ‘identifying, in-licensing and developing high-potential
marketed drugs and development-stage drug candidates.’
The company’s current product portfolio
includes five prescription pharmaceuticals. Additionally, it has 25 more
products in development stages.
Just last year in 2019, consulting giant
Deloitte named Fortress Biotech as a top ten Technology Fast 500™ companies.
This list ranks the ‘fastest-growing North American companies in the
technology, media, telecommunications, life sciences, and energy tech sectors’.
Deloitte uses the percentage of a company’s fiscal year revenue growth over 3
years to compile these rankings. Fortress Biotech was ranked in tenth
One of the main ways that Fortress Biotech
achieves growth and financial returns for investors is through partnerships.
These partnerships are typically with other
pharmaceutical companies as well as academic and research institutions. Some of
their high-profile partnerships include Alexion Pharmaceuticals, Inc., Fred
Hutchinson Cancer Research Center, and InvaGen Pharmaceuticals Inc. They also
have a partnership with St. Jude Children’s Research Hospital.
In 2019, Fortress Biotech stock, FIBO, grew 7.5% in December. This was likely due to the company’s announcement that it had reached a worldwide licensing agreement with AstraZeneca. The company also announced a new collaboration project with the Cincinnati Children’s Hospital Medical Center.
According to a press release issued on the
Fortress Biotech website, the agreement with AstraZeneca is to license the
drug, AZD7325. With Cincinnati Children’s Hospital Medical Center, they will
work together ‘to advance clinical development in select central nervous
systems (“CNS”) disorders’.
The company currently operates out of a 24,000
square-foot office space in Manhattan. According to reports, those who invested
in the stock before December 24th profited by $1/share.
Rosenwald’s 5,000+ Square-foot
Penthouse for Sale
is not only a great businessman at work with Fortress Biotech. He also has
several successful investments in his private life; specifically in real
of these investments is located at 15 Central Park West in the affluent Upper
West Side. The building was designed by renowned architect, Robert A.M. Stern
and attracts high-end, luxury residents. Rosenwald’s corner penthouse in the
building is nearly 6,000 square feet.
on the 18th and 19th floor, the apartment is modern, spacious, and luxurious.
to the property listing, the apartment has two terraces that both face Central
Park. One terrace reportedly ‘wraps around nearly the entire 18th floor’.
Additionally, the apartment has a ‘private elevator, gas fireplace,
individually zoned central ac/heat, custom closets plus motorized shades and
The 18th floor of the property is designed perfectly for
entertaining. It features a grand dining room, reception area, powder room, and
full-size kitchen with extra space for service staff.
The 19th floor features the more private areas. These
include a master bedroom suite with walk-in closets and dressing areas, a
sitting room, and two additional full bathrooms. The master suite also features
an outdoor balcony. Also on the 19th floor are three more bedrooms with ensuite
bathrooms and a laundry room.
Other rooms in the apartment include a wine cellar, two
storage units, a study/library, and a dining room. There is also a studio
apartment/service suite fitted with a private closet, bathroom, and
originally purchased the property for $30.55 million, however it is currently
worth double that amount. Rosenwald currently has the property listed at $65
The Neighborhood: 15 Central Park
Lindsay Rosenwald has definitely fit in well at the exclusive 15 Central
Park West facility.
The building itself boasts a number of luxury features and amenities loved by its high-income clientele. This includes a private restaurant, screening room, billiard room, and business center. There is also a health club, entertainment suite, and library. Other moguls and billionaires currently living at 15 Central Park West include Anheuser-Busch InBev shareholder, Marcel Herrmann Telles. Russian billionaire, Dmitry Rybolovlev, and his daughter also reportedly have a space there. Other residents include former CEO of Goldman Sachs, Lloyd Blankfein, and Chairman of Walt Disney Studios, Alan Horn, among others.